Literature DB >> 29223130

The expression of the embryonic gene Cripto-1 is regulated by OCT4 in human embryonal carcinoma NCCIT cells.

Sung-Won Park1, Hyun-Jin Do1, Mi-Hee Han1, Wonbin Choi1, Jae-Hwan Kim1.   

Abstract

Cripto-1 and OCT4, expressed in stem cells and cancers, play important roles in tumorigenesis. Here, we demonstrate that Cripto-1 expression is regulated by OCT4 in human embryonic carcinoma NCCIT cells. The endogenous expression of Cripto-1 and OCT4 is significantly reduced during differentiation. Cripto-1 expression is increased by OCT4 overexpression, but decreased by shRNA-mediated OCT4 knockdown. OCT4 overexpression significantly activates Cripto-1 transcriptional activity. A 5'-upstream minimal promoter sequence in the gene-encoding Cripto-1 is significantly activated by OCT4 overexpression. Mutation of the putative OCT4-binding site abolishes OCT4-mediated activation of the Cripto-1 promoter. The OCT4 transactivation domains mediate transcriptional activity of the Cripto-1 minimal promoter through direct interaction. Taken together, OCT4 plays an important role as a transcriptional activator of Cripto-1 expression in NCCIT cells.
© 2017 Federation of European Biochemical Societies.

Entities:  

Keywords:  Cripto-1; NCCIT cells; OCT4; minimal promoter; transcriptional activity

Mesh:

Substances:

Year:  2017        PMID: 29223130     DOI: 10.1002/1873-3468.12935

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Identification of myosin II as a cripto binding protein and regulator of cripto function in stem cells and tissue regeneration.

Authors:  Malachia Hoover; Farhana Runa; Evan Booker; Jolene K Diedrich; Erika Duell; Blake Williams; Caroline Arellano-Garcia; Toni Uhlendorf; Sa La Kim; Wolfgang Fischer; James Moresco; Peter C Gray; Jonathan A Kelber
Journal:  Biochem Biophys Res Commun       Date:  2018-12-20       Impact factor: 3.575

2.  Administration of Cripto in GRP78 overexpressed human MSCs enhances stem cell viability and angiogenesis during human MSC transplantation therapy.

Authors:  S Kim; Y M Yoon; Y-S Han; J H Lee; J Hur; S H Lee
Journal:  Cell Prolif       Date:  2018-05-02       Impact factor: 6.831

3.  Luteolin Inhibits Breast Cancer Stemness and Enhances Chemosensitivity through the Nrf2-Mediated Pathway.

Authors:  Kuen-Jang Tsai; Hsin-Yi Tsai; Chin-Chuan Tsai; Tai-Yu Chen; Tsung-Hua Hsieh; Chun-Lin Chen; Lulekiwe Mbuyisa; Yaw-Bin Huang; Ming-Wei Lin
Journal:  Molecules       Date:  2021-10-26       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.